Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Women with PCOS and polycystic ovaries have higher male hormone levels and more insulin resistance, especially if they are overweight.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

Estrogens are key for bone growth spurts in both boys and girls and affect growth into adulthood.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

Testosterone is crucial for development, growth, and various body functions in mammals.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Insulin resistance is linked to larger thyroid volume in patients with polycystic ovary syndrome.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Low-dose gonadotropin treatment is effective for infertility in women with PCOS, leading to high ovulation rates and comparable pregnancy rates with fewer complications.

The link between physical signs of high male hormones and hormone levels in women with PCOS changes with age.

The document does not determine if adults with aphallia are fertile.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Hormonal changes and conditions like polycystic ovarian syndrome are major causes of adult acne in women, with varying prevalence among different ethnicities.

There are various effective hormone treatments for puberty induction in boys and girls with hypogonadism, and starting treatment early is important.

More research is needed to understand how testosterone is maintained in adult males.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Metformin lowers prolactin in women without PCOS but not in those with PCOS, where it reduces other hormones instead.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.